On September 26, 2023, Nexus Pharmaceuticals, LLC[1] announced[2] that it had received approval from the U.S. Food and Drug Administration (FDA) for Fluorescein Injection, USP. Nexus Pharmaceuticals ...
A temporal change in the titania surface chemical state during the UV light irradiation is not observable through conventional methods such as regular FTIR or Raman spectroscopy. Therefore, a team led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results